This is a novel syndrome of growth retardation that presents with progressive growth failure with markedly elevated circulating IGF‐I, IGF‐II, IGFBP‐3, IGFBP‐5, and ALS, but decreased fIGF‐I levels and IGF bioactivity. Here, IGFBP3 is linked to amyotrophic lateral sclerosis.